In a Huffington Post opinion piece, Gro Brundtland, a member of the U.N. Foundation board of directors, former WHO director general and former prime minister of Norway, discusses global progress on childhood vaccines. Brundtland discusses the upcoming launch of the U.N. Foundation’s global vaccines campaign aimed at inspiring Americans “to provide children in the developing world with immunizations against deadly diseases.”
Owen Barder, a visiting fellow at the Center for Global Development, examines the relationship among aid donors, GAVI and pharmaceutical companies in a post on the center’s “Global Health Policy” blog.
Syndicated columnist and ONE senior adviser Michael Gerson, in a CNN opinion piece, reviews the documentary “Voodoo and Vaccines,” which he writes “shows how government and health officials have reached out to religious leaders, and how many traditional healers are now carrying a pro-vaccination message. They are combining a belief in traditional medicine with an acceptance of modern medicine. And this is benefiting the people of Benin.”
As Tachi Yamada, president of global health at the Bill & Melinda Gates Foundation, prepares to leave the foundation this month, Nature News interviewed him about his work at the Gates Foundation and his predictions for global health.
The final phase of testing for GlaxoSmithKline Biologicals’ malaria vaccine, RTS,S, is underway in seven sub-Saharan African countries, and “[i]f the results, due to be released later this, year confirm the vaccine’s efficacy in preventing malaria, it could be made available as early as 2015,” IRIN reports.
The success of antiretroviral therapy for HIV/AIDS “has fooled us into believing HIV is under control. It is not. â€¦ The fact remains that no sexually acquired infection has ever been controlled in democratic societies except by vaccines,” Lawrence Corey, president and director of the Fred Hutchinson Cancer Research Center and principal investigator of the international HIV Vaccine Trials Network, writes in a Wall Street Journal opinion piece.
“A vaccine to prevent cervical cancer, triggered by the human papillomavirus (HPV), has helped reduce the number of teenage girls developing abnormalities in their cervix by as much as 50 percent in a study in Australia,” according to a report published Friday in the Lancet, Reuters reports.
The Economist examines how “the past decade has seen changes in how vaccines are developed, financed and delivered â€“ solving, at least partially, the conundrum of the vaccine market: poor regions have ample demand for vaccines but little ability to pay for them. As a result, immunisation rates in the poor world have soared.”
Commenting on the U.S. pledge of $450 million to the GAVI Alliance, Gayle Smith, special assistant to the President and senior director for Development and Democracy for the National Security Staff, writes in a White House Blog post, “Investments in vaccines are one of the best and most cost-effective life-saving…
“I can’t help worrying that, as donors slap themselves on the back over their generosity [shown through pledges to the GAVI Alliance] â€¦, their feelgood factor will turn into a warm glow of satisfaction at having played out their part. Problem solved,” Sarah Boseley writesÂ on the Guardian’sÂ “Global Health Blog.” “What…